Medios AG
XETRA:ILM1
Intrinsic Value
Medios AG is a holding company, which engages in the provision of pharmaceutical drugs. [ Read More ]
The intrinsic value of one ILM1 stock under the Base Case scenario is 34.52 EUR. Compared to the current market price of 14.36 EUR, Medios AG is Undervalued by 58%.
Valuation Backtest
Medios AG
Run backtest to discover the historical profit from buying and selling ILM1 stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Medios AG
Current Assets | 269.2m |
Cash & Short-Term Investments | 71m |
Receivables | 127.2m |
Other Current Assets | 70.9m |
Non-Current Assets | 325.6m |
Long-Term Investments | 647k |
PP&E | 37.1m |
Intangibles | 287.8m |
Current Liabilities | 83.2m |
Accounts Payable | 52.8m |
Other Current Liabilities | 30.4m |
Non-Current Liabilities | 42.7m |
Long-Term Debt | 14.7m |
Other Non-Current Liabilities | 28.1m |
Earnings Waterfall
Medios AG
Revenue
|
1.8B
EUR
|
Cost of Revenue
|
-1.7B
EUR
|
Gross Profit
|
109.6m
EUR
|
Operating Expenses
|
-78.2m
EUR
|
Operating Income
|
31.3m
EUR
|
Other Expenses
|
-12.5m
EUR
|
Net Income
|
18.8m
EUR
|
Free Cash Flow Analysis
Medios AG
What is Free Cash Flow?
ILM1 Profitability Score
Profitability Due Diligence
Medios AG's profitability score is 48/100. The higher the profitability score, the more profitable the company is.
Score
Medios AG's profitability score is 48/100. The higher the profitability score, the more profitable the company is.
ILM1 Solvency Score
Solvency Due Diligence
Medios AG's solvency score is 90/100. The higher the solvency score, the more solvent the company is.
Score
Medios AG's solvency score is 90/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
ILM1 Price Targets Summary
Medios AG
According to Wall Street analysts, the average 1-year price target for ILM1 is 31.62 EUR with a low forecast of 25.25 EUR and a high forecast of 42 EUR.
Shareholder Return
ILM1 Price
Medios AG
Average Annual Return | 11.58% |
Standard Deviation of Annual Returns | 49.68% |
Max Drawdown | -67% |
Market Capitalization | 341.9m EUR |
Shares Outstanding | 23 805 723 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Medios AG is a holding company, which engages in the provision of pharmaceutical drugs. The company is headquartered in Berlin, Berlin and currently employs 301 full-time employees. The company wholesales, markets, distributes and produces various kinds of goods for pharmacies and other pharmaceutical companies. The firm also provides related services and is engaged in the acquisition and management of other companies from the pharmaceutical industry.
Contact
IPO
Employees
Officers
The intrinsic value of one ILM1 stock under the Base Case scenario is 34.52 EUR.
Compared to the current market price of 14.36 EUR, Medios AG is Undervalued by 58%.